House passes bill to suspend tariffs on imported infant formula base powders
The House today passed legislation that would suspend through 2022 tariffs on certain infant formula base powders used to make infant formula in the United States. Congress in July passed legislation (H.R.8351) suspending tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage to help health care providers and families locate formula.
Related News Articles
Headline
House passes CR to fund government through Dec. 4 and budget resolution for next reconciliation bill
The House July 21 passed a continuing resolution that would fund the government through Dec. 4 by a 220-205 vote. The CR does not include extensions of key…
Headline
The AHA provided comments July 21 to the Senate Committee on Health, Education, Labor and Pensions on price transparency, nursing workforce and rural…
Headline
The House Budget Committee July 16 passed a budget resolution by a 20-14 vote along party lines during a markup, paving the way for a new reconciliation bill…
Headline
AHA Board Chair Marc Boom, M.D., took the stage July 13 to introduce AHA award winners and a town hall discussion on navigating the 2026 political…
Headline
The House Energy and Commerce Subcommittee on Health June 25 held a markup session on bills regarding healthcare price transparency, illicit drugs …
Headline
The AHA provided a statement to the House Energy and Commerce Subcommittee on Health today for a hearing titled “Lowering Health Care Costs for All Americans:…